Phyllis Hollander

1.6k citations
13 papers · 1.2k · 2 hit papers · h-index 7

Impact in

  • Surgery top 2%
    • Bladder and Urothelial Cancer Treatments
    • Urinary and Genital Oncology Studies
  • Urology top 5%
    • Urological Disorders and Treatments

Papers in

    • Urinary and Genital Oncology Studies 6
    • Bladder and Urothelial Cancer Treatments 6
    • Cancer Treatment and Pharmacology 2
    • Colorectal Cancer Treatments and Studies 2

Phyllis Hollander

13 papers receiving 1.2k citations

Phyllis Hollander's Hit Papers

M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium 1988 · 494 citations
4940+13+27Years since publication100200300400500

Peers

Phyllis Hollander
Comparison fields: 5 of 55
  • Surgery 1.0k
  • Urology 113
  • Oncology 319
  • Pulmonary and Respiratory Medicine 213
  • Pathology and Forensic Medicine 62
Replace Rafael J. Luque with:
Rafael J. Luque Spain
Dharamdas M. Ramnani United States
Jürgen F. Linn United States
Johannes Giedl Germany
Takayoshi Sekikawa Japan
F. Desgrandchamps France
Riley E. Alexander United States
Sakae Nagaoka Japan
Stuart M. Bergman United States
G.N. Thalmann Switzerland
Phyllis Hollander relative to Rafael J. Luque Spain Rafael J. Luque's profile →
Citations per field
00.5×2.5×
Rafael J. Luque · 1×
Citations per year

Countries citing papers authored by Phyllis Hollander

Since Specialization
Citations

This map shows the geographic impact of Phyllis Hollander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Hollander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Hollander more than expected).

Fields of papers citing papers by Phyllis Hollander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis Hollander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Hollander. The network helps show where Phyllis Hollander may publish in the future.

Co-authors

The 25 scholars most cited alongside Phyllis Hollander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phyllis Hollander Line = papers co-authored together Phyllis Hollander links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium
Hit paper breakdown →
1985513
2
M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium
Hit paper breakdown →
1988494
3 1988161
4 198615
5
Phase II trial of N-methylformamide for advanced renal cell carcinoma.
198612
6 198810
7 19877
8
Phase II trial of 10-deazaaminopterin for advanced hypernephroma.
19856
9 19884
10
Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
19864
11 19872
12 19861
13
The Complete Book of Cheerleading
19751

About Phyllis Hollander

Phyllis Hollander is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry and Molecular Biology, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Urinary and Genital Oncology Studies (6 papers), Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (3 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Surgery (1.0k citations), Urology (113 citations), Oncology (319 citations), Pulmonary and Respiratory Medicine (213 citations) and Pathology and Forensic Medicine (62 citations). Phyllis Hollander has collaborated with scholars based in United States. Frequent co-authors include Nancy L. Geller, Cora N. Sternberg, Howard I. Scher, Robin C. Watson, Alan Yagoda, Pramod C. Sogani, Harry W. Herr, Michael J. Morse, Willet F. Whitmore and Lora Weiselberg. Their work appears in journals such as The Journal of Urology, Cancer Chemotherapy and Pharmacology, American Journal of Clinical Oncology, PubMed and Medical Entomology and Zoology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact